SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : progenics
PGNX 4.100-9.4%Jun 19 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: MskiHntr who wrote (26)1/6/1999 1:02:00 AM
From: Larry Liebman  Read Replies (1) of 139
 
Took a position at $12 3/8. PGNX has floundered of late. Spoke with IR. Their take: (a) Lack of news and (b) Lack of visibility- i.e., 8600 shares traded today. In terms of progress in programs, the response was that "There is absolutely no adverse news to report". They will do the dog and pony show in Europe, attend H&Q. With the melanoma vaccine in Phase 3 with BMY, cutting edge AIDS research, etc., it's worth some due diligence at this level.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News